## Antibiotic Therapy in Acute Appendicitis **Key Point:** Acute appendicitis requires broad-spectrum coverage against gram-negative aerobes and anaerobes. The combination of a third-generation cephalosporin with metronidazole is the gold standard for uncomplicated appendicitis. ### Rationale for Ceftriaxone + Metronidazole 1. **Spectrum Coverage** - Ceftriaxone covers gram-negative aerobes (E. coli, Klebsiella, Proteus) - Metronidazole covers anaerobes (Bacteroides, Peptostreptococcus, Clostridium) - Combined regimen covers the polymicrobial flora of the appendix 2. **Dosing in Acute Appendicitis** - Ceftriaxone: 1–2 g IV every 12 hours - Metronidazole: 500 mg IV every 8 hours **High-Yield:** The appendix contains both aerobic and anaerobic bacteria; monotherapy is inadequate. Dual coverage is mandatory even in uncomplicated cases to prevent surgical site infections and sepsis. **Clinical Pearl:** In penicillin-allergic patients, fluoroquinolone (ciprofloxacin) + metronidazole is an acceptable alternative, but the cephalosporin combination remains first-line due to superior beta-lactamase inhibition. ### Alternative Regimens | Scenario | First-Line | Alternative | | --- | --- | --- | | Uncomplicated appendicitis | Ceftriaxone + metronidazole | Cefoxitin (single agent) | | Perforated appendicitis | Ceftriaxone + metronidazole ± gentamicin | Piperacillin-tazobactam | | Penicillin allergy | Fluoroquinolone + metronidazole | Clindamycin + gentamicin | **Warning:** Amoxicillin-clavulanate monotherapy is inadequate for appendicitis because it does not reliably cover all anaerobes and gram-negative organisms. Fluoroquinolone monotherapy lacks anaerobic coverage. Clindamycin alone is outdated and does not cover gram-negative aerobes.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.